Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Response to comment on "dimethyl fumarate (tecfidera): a new oral agent for multiple sclerosis".
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.
Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.
Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis.
JC Virus Replication at the First Symptoms of Multiple Sclerosis: A Case Report.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
Safety of TNF inhibitors in adolescents and children.
Clinically isolated syndrome manifested as acute vestibular syndrome: Bedside neuro-otological examination and suppression of transient evoked otoacoustic emissions in the differential diagnosis.
A unified cell biological perspective on axon-myelin injury.
Smoking as a risk factor for multiple sclerosis.
Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.
Improving adherence to injectable disease-modifying drugs in multiple sclerosis.
Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
Self-reported use of the upper limbs related to clinical tests in persons with multiple sclerosis.
Identification of a Selective RORγ Ligand That Suppresses T(H)17 Cells and Stimulates T Regulatory Cells.
Unusual Manifestations of Pediatric Neuromyelitis Optica.
Exome sequencing identifies a novel, multiple sclerosis susceptibility variant in the TYK2 gene.
Intrathecal baclofen in multiple sclerosis.
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Learning a cost function for microscope image segmentation.
Pages
« first
‹ previous
…
389
390
391
392
393
394
395
396
397
…
next ›
last »